Fractyl Health, Inc. (GUTS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Fractyl Health, Inc. (GUTS) closed at USD 4.08 on 2026-10-14, a change of -73.4 % over the past year, with a market capitalization of USD 55.18M.

Fractyl Health, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Fractyl Health, Inc. key figures

Previous close

USD 4.08 (2026-10-14)

1-year change

-73.4 %

Market cap

USD 55.18M

Enterprise value

USD 68.78M

P/E ratio (trailing)

-0.38

P/E ratio (forward)

-0.87

EPS (trailing)

-10.93

EPS (forward)

-4.78

PEG ratio

n/a

Price to book

-33.02

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.19

Employees

100

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Fractyl Health, Inc.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Fractyl Health, Inc. and compare it with other stocks.